Aripiprazole Treatment of Prodromal Patients

Completed · Phase 2/Phase 3

Conditions studied: Schizophrenia, Psychosis

In brief

We hypothesize that symptoms will improve in patients who meet diagnostic criteria for the schizophrenia prodrome when they are prescribed aripiprazole.

Key facts

Study ID

NCT00237874

Run by

Yale University

People needed

15

Starts

2004-02-01

Expected to finish

2007-02-01

Last updated by the study team

2014-06-06

Who can join

Age: 13 and older, up to 40. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age 13 to 40 meet criteria for the prodrome for schizophrenia

You may not qualify if…

• history of psychosis

Where it is running

• Institute of Living — Hartford, Connecticut, United States
• Yale School of Medicine — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.